Alexandros Xyrafas

Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial

Miklos Pless, Roger Stupp, Hans-Beat Ris et al. · The Lancet · 2015 · 390 citations

Medicine, Oncology, Radiation Oncology +13

Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors

Giuseppe Curigliano, Hans Gelderblom, Nicolas Mach et al. · Clinical Cancer Research · 2021 · 348 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial

Rolf A. Stahel, Oliver Riesterer, Alexandros Xyrafas et al. · The Lancet Oncology · 2015 · 201 citations

Medicine, Oncology, Surgery +15

Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study

Vasilis Georgoulias, V. Bozionelou, Sofia Agelaki et al. · Annals of Oncology · 2012 · 150 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Baseline nutritional evaluation in metastatic lung cancer patients: Mini Nutritional Assessment versus weight loss history

Ioannis Gioulbasanis, Vickie E. Baracos, Zoe Giannousi et al. · Annals of Oncology · 2010 · 95 citations

Agriculture, Nutritional Sciences, Oncology +17